Michael Krychman, MD

Michael L. Krychman, MD, and Jack D. Sobel, MD, discuss the importance of awareness and education about RVVC, particularly given the impact of symptoms on patients’ psychosocial and sexual behavior.

Michael L. Krychman, MD, and Jack D. Sobel, MD, discuss the practical challenges of access to newer, FDA-approved medications for RVVC and how the third-party reimbursement landscape may take shape in coming years.

Experts explore the availability and cost as well as other unanswered questions regarding emerging agents for the treatment of RVVC.

Michael L. Krychman, MD, and Jack D. Sobel, MD, review the mechanisms of ibrexafungerp and how it might fit in the treatment spectrum for RVVC.

Michael L. Krychman, MD, and Jack D. Sobel, MD, review the clinical implications of the recent approval of oteseconazole, which has been shown to be efficacious and well tolerated in RVVC treatment.

Thought leaders discuss the history of RVVC treatment, including the use of unapproved topical antifungals and the shortcomings of fluconazole.

Michael L. Krychman, MD, and Jack D. Sobel, MD, explore avenues for confirming a diagnosis of RVVC, including cultures and molecular testing.

Michael L. Krychman, MD, and Jack D. Sobel, MD, review diagnostic criteria of diagnosis of RVVC and the impact of misdiagnosis.

Michael L. Krychman, MD and Jack D. Sobel, MD, talk about the signs and symptoms of vulvovaginal candidiasis as well as its effect on patient quality of life.

Top takeaways from ISSWSH 2022

In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.

In this video, Barb Dehn, NP, discusses Brexafemme, the first fungicidal medication approved for the treatment of vulvovaginal candidiasis.

In this episode, Michael Krychman, MD, sat down with Alyssa Dweck, MD, gynecologist, and Bonafide medical advisor to catch up at this year's North American Menopause Society (NAMS) Annual Meeting.

Michael Krychman, MD discusses his perspective as a physician during the second wave of COVID-19, and shares some insight into ways other health care professionals can cope.

Angie DeRosa, Senior Editor at Contemporary OB/GYN®, interviewed Michael Krychman, MD, about the importance of creating an affirming environment in medical facilities for the LGBTQ+ community. He is the executive director of the Southern California Center for Sexual Health and Survivorship in Newport Beach, Calif.

In this video, Angie DeRosa, senior editor of Contemporary OB/GYN®, interviews Michael Krychman, MD, a gynecologist who specializes in sexual health and survivorship medicine.

These therapeutic medical devices can be used by patients to effectively treat pelvic pain and anxiety related to intercourse.

Patients and practitioners may be hesitant to delve into sexual health, but talking about it is one way to normalize it.